The world will remember 2020 as the worst year and it will be etched in our minds and hearts for a long time. However, 2021 offers some for humanity against Covid. The two vaccines approved in the US have a 95 per cent efficacy rate against the virus. The vaccines approved for India do not clearly specify the efficacy rates. Reports list the same in the range of 70 per cent. Is it worth the amount of money and logistics to push a 70 per cent efficacy rate vaccine when 95 per cent efficacy ones are available? Post-vaccination, we still require to follow social distancing and wear masks. Indians’ penchant for flouting these norms, even when a mutant, fast-spreading virus is lurking around calls for a review of the vaccination programme. Imagine the efforts, logistics and costs involved in the vaccination drive in a populous country like India.
